MENU
EQ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Equillium (EQ) Ownership - Who owns Equillium?
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.79M
P/E Ratio
N/A
Total Cash
25.88M
Projected Growth
N/A
Total Debt
497K
Revenue
45.91M
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
1.16 USD as % of share price
Fundamentals
EQ
Capitalization
16.8M
P/E Ratio
N/A
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash
25.9M
Total Cash/Share
0.72
Total Debt
497K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.16%
Revenue
45.9M
ROE
N/A
Book Value
23.2M
P/B Ratio
0.88
Cash Flow
N/A
Earnings
-0.12
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
3.04
Current Revenue Per Employee
270244.44
Dividends Per Share - Security
N/A
EBITDA
-4.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-10.29
Shares Held By Institutions
7.13M
Shares Outstanding - Current
35.7M
Total Liabilities
11.3M
Total Volume MTD
N/A
Value
1
Gain YTD
-37.183
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of products for severe immune-inflammatory disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com